Actinium Pharmaceuticals, Inc. (ATNM)
NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 11:20AM EDT. Market open.
| Previous Close | 6.30 |
| Open | 6.26 |
| Bid | 6.21 x 1100 |
| Ask | 6.23 x 1100 |
| Day's Range | 6.18 - 6.28 |
| 52 Week Range | 5.87 - 15.12 |
| Volume | |
| Avg. Volume | 166,857 |
| Market Cap | 169.329M |
| Beta (5Y Monthly) | 0.38 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.83 |
| Earnings Date | Nov 14, 2023 - Nov 29, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 27.60 |
ZacksFinch Therapeutics Group, Inc. (FNCH) Reports Q3 Loss, Misses Revenue Estimates
Finch Therapeutics Group, Inc. (FNCH) delivered earnings and revenue surprises of -12.50% and 90.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ZacksActinium (ATNM) Stock Jumps 8.6%: Will It Continue to Soar?
Actinium (ATNM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
© 2023 Yahoo. All rights reserved.
